Sisäpiiritieto: Nexstim Oyj ilmoittaa lisätietoja liittyen Magnus Medical, Inc.:n teknologian lisensointisopimukseen
June 12, 2024 02:00 ET
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 12.06.2024 klo. 9.00 (EEST) Sisäpiiritieto: Nexstim Oyj ilmoittaa lisätietoja liittyen Magnus Medical, Inc.:n teknologian lisensointisopimukseen Nexstim Oyj (NXTMH:HEX)...
Insider Information: Nexstim Plc Provides Further Details on Technology License Agreement with Magnus Medical, Inc.
June 12, 2024 02:00 ET
|
Nexstim Oyj
Company announcement, Helsinki, 12 June 2024 at 9 AM (EEST) Insider Information: Nexstim Plc Provides Further Details on Technology License Agreement with Magnus Medical, Inc. Nexstim Plc...
Nexstim Oyj: Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus huomattavasta omistusosuudesta
June 11, 2024 07:00 ET
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 11.6.2024 klo. 14.00 (EEST) Nexstim Oyj: Arvopaperimarkkinalain 9 luvun 10 §:n mukainen ilmoitus huomattavasta omistusosuudesta Nexstim Oyj (NXTMH:HEX) (”Nexstim” tai...
Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act
June 11, 2024 07:00 ET
|
Nexstim Oyj
Company announcement, Helsinki, 11 June 2024 at 2 PM (EEST) Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act Nexstim Plc...
Distributor Orders Nexstim NBS System 5 for European Hospital
June 10, 2024 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 10 June 2024 at 9 AM (EEST) Distributor Orders Nexstim NBS System 5 for European Hospital Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS...
Sisäpiiritieto: Nexstim Oyj tiedottaa suunnitellusta yhteistyöstä Sinaptica Therapeutics, Inc:n kanssa Alzheimerin taudin hoidon alalla
June 07, 2024 02:00 ET
|
Nexstim Oyj
Yhtiötiedote, Helsinki, 07.06.2024 klo. 9.00 (EEST) Sisäpiiritieto: Nexstim Oyj tiedottaa suunnitellusta yhteistyöstä Sinaptica Therapeutics, Inc:n kanssa Alzheimerin taudin hoidon alalla Nexstim...
Insider Information: Nexstim Plc Announces Planned Alzheimer’s Collaboration with Sinaptica Therapeutics, Inc.
June 07, 2024 02:00 ET
|
Nexstim Oyj
Company announcement, Helsinki, 7 June 2024 at 9 AM (EEST) Insider Information: Nexstim Plc Announces Planned Alzheimer’s Collaboration with Sinaptica Therapeutics, Inc. Nexstim Plc (NXTMH:HEX)...
Finnish Hospital Orders Nexstim NBS System 5
May 08, 2024 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 8 May 2024 at 9 AM (EEST) Finnish Hospital Orders Nexstim NBS System 5 Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a...
Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
May 06, 2024 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 6 May 2024 at 9 AM (EEST) Health Canada Approves Nexstim NBS 6 System for Treatment of MDD Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received approval from...
Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market
May 03, 2024 03:00 ET
|
Nexstim Oyj
Press release, Helsinki, 3 May 2024, 10 AM (EEST) Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces that...